Complex controls: the role of alternative promoters in mammalian genomes

被引:256
作者
Landry, JR
Mager, DL [1 ]
Wilhelm, BT
机构
[1] Univ British Columbia, Terry Fox Lab, British Columbia Canc Agcy, Vancouver, BC V5Z 1L3, Canada
[2] Univ British Columbia, Terry Fox Lab, Dept Med Genet, Vancouver, BC V5Z 1L3, Canada
基金
加拿大健康研究院;
关键词
D O I
10.1016/j.tig.2003.09.014
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Despite the wealth of sequence data available from human, mouse and other genomes, our understanding of the mechanisms involved in regulating transcription and creating protein diversity is incomplete. Although effects such as alternative splicing have been extensively studied, other less well-characterized phenomena are now being recognized that increase the complexity of the transcribed portion of the genome. One mechanism, supported by a growing body of research, is the use of alternative promoters. In this article, we describe the consequences and significance of alternative promoter usage in human and mouse genomes, demonstrating that mammalian genes commonly employ multiple promoters to regulate and increase their transcriptional and translational potential.
引用
收藏
页码:640 / 648
页数:9
相关论文
共 62 条
  • [1] Human uroporphyrinogen-III synthase: Genomic organization, alternative promoters, and erythroid-specific expression
    Aizencang, G
    Solis, C
    Bishop, DF
    Warner, C
    Desnick, RJ
    [J]. GENOMICS, 2000, 70 (02) : 223 - 231
  • [2] Uroporphyrinogen III synthase - An alternative promoter controls erythroid-specific expression in the murine gene
    Aizencang, GI
    Bishop, DF
    Forrest, D
    Astrin, KH
    Desnick, RJ
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (04) : 2295 - 2304
  • [3] The gene encoding Disabled-1 (DAB1), the intracellular adaptor of the reelin pathway, reveals unusual complexity in human and mouse
    Bar, I
    Tissir, F
    de Rouvroit, CL
    De Backer, O
    Goffinet, AM
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (08) : 5802 - 5812
  • [4] A transcription factor regulatory circuit in differentiated pancreatic cells
    Boj, SF
    Párrizas, M
    Maestro, MA
    Ferrer, J
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (25) : 14481 - 14486
  • [5] An alternative, human SRC promoter and its regulation by hepatic nuclear factor-1α
    Bonham, K
    Ritchie, SA
    Dehm, SM
    Snyder, K
    Boyd, FM
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (48) : 37604 - 37611
  • [6] A novel Dnmt3a isoform produced from an alternative promoter localizes to euchromatin and its expression correlates with active de novo methylation
    Chen, TP
    Ueda, Y
    Xie, SP
    Li, E
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (41) : 38746 - 38754
  • [7] Autoregulation of NFATc1/A expression facilitates effector T cells to escape from rapid apoptosis
    Chuvpilo, S
    Jankevics, E
    Tyrsin, D
    Akimzhanov, A
    Moroz, D
    Jha, MK
    Luehrmann, JS
    Santner-Nanan, B
    Feoktistova, E
    König, T
    Avots, A
    Schmitt, E
    Berberich-Siebelt, F
    Schimpl, A
    Serfling, E
    [J]. IMMUNITY, 2002, 16 (06) : 881 - 895
  • [8] Coupling of transcription with alternative splicing:: RNA pol II promoters modulate SF2/ASF and 9G8 effects on an exonic splicing enhancer
    Cramer, P
    Cáceres, JF
    Cazalla, D
    Kadener, S
    Muro, AF
    Baralle, FE
    Kornblihtt, AR
    [J]. MOLECULAR CELL, 1999, 4 (02) : 251 - 258
  • [9] The organization, promoter analysis, and expression of the human PPAR gamma gene
    Fajas, L
    Auboeuf, D
    Raspe, E
    Schoonjans, K
    Lefebvre, AM
    Saladin, R
    Najib, J
    Laville, M
    Fruchart, JC
    Deeb, S
    VidalPuig, A
    Flier, J
    Briggs, MR
    Staels, B
    Vidal, H
    Auwerx, J
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (30) : 18779 - 18789
  • [10] Transactivation-deficient p73α (p73Δexon2) inhibits apoptosis and competes with p53
    Fillippovich, I
    Sorokina, N
    Gatei, M
    Haupt, Y
    Hobson, K
    Moallem, E
    Spring, K
    Mould, M
    McGuckin, MA
    Lavin, MF
    Khanna, KK
    [J]. ONCOGENE, 2001, 20 (04) : 514 - 522